Ömer Araz

Ömer Araz

Auto-generated profile, based on publicly available information

Ömer Araz

Department of Pulmonary Medicine, Atatürk University Faculty of Medicine, Erzurum, Türkiye

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 December 2020 in Biomaterials
Verified
Journal Article
Closed access
SHStefan Harmsen
Stefan Harmsen
EMEmin Ilker Medine
Emin Ilker Medine
MMMaxim Moroz
Maxim Moroz
FNFuad Nurili
Fuad Nurili
JLJose Lobo
Jose Lobo
FMFazilet Zumrut Biber Muftuler
Fazilet Zumrut Biber Muftuler

1 September 2021 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MZMengjiao Zhou
Mengjiao Zhou
SHShupeng Han
Shupeng Han
FMFazilet Zumrut Biber Muftuler
Fazilet Zumrut Biber Muftuler
FAFeifei An
Feifei An
Paclitaxel (PTX) is the first natural plant-derived chemotherapeutic drug approved by the Food and Drug Administration. However, the clinical applications of PTX are limited by some drawbacks, such as poor water solubility, rapid blood clearance, nonspecific distribution, and adverse side effects. Nanocarriers have made important contributions to drug delivery and cancer therapy in recent years. However, low drug loading capacity, nanocarrier excipients-induced toxicity or immunogenicity, and complicated synthesis technologies pose a challenge for the clinical application of nanocarriers. To address these issues, the self-delivery nanomedicine (SDNs), in which pure drug molecules directly self-assemble into nanomedicine, have been developed for drug delivery and enhancing antitumor efficacy. In this review, we comprehensively summarize the recent advances in PTX-based SDNs for cancer therapy. First, the self-assembly strategies to develop pure PTX nanodrugs are discussed. Then, the emerging strategies of co-assembly PTX and other therapeutic agents for effective combination therapy are presented, composing of combination chemotherapy, chemo-photothermal therapy, chemo-photodynamic therapy, chemo-immunotherapy, and chemo-gene therapy. Finally, the limitations and future outlook of SDNs are discussed. The rational design of these unique nanoplatforms may make a new direction to develop highly efficient drug delivery systems for cancer therapy.

20 April 2018 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HKHarikrishna Kommidi
Harikrishna Kommidi
HGHua Guo
Hua Guo
FNFuad Nurili
Fuad Nurili
YVYogindra Vedvyas
Yogindra Vedvyas
MJMoonsoo M. Jin
Moonsoo M. Jin
RTRichard Ting
Richard Ting

3 July 2017 in Cellular and Molecular Life Sciences
Verified
Journal Article
Closed access
PDF file
PJPiotr Jurgielewicz
Piotr Jurgielewicz
SHStefan Harmsen
Stefan Harmsen
EWElizabeth Wei
Elizabeth Wei
MBMichael H. Bachmann
Michael H. Bachmann
RTRichard Ting
Richard Ting
FMFazilet Zumrut Biber Muftuler
Fazilet Zumrut Biber Muftuler

4 February 2014 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
EUElif Yilmazel Ucar
Elif Yilmazel Ucar
OAOmer Araz
Omer Araz
NYNafiye Yilmaz
Nafiye Yilmaz
MAMetin Akgün
Metin Akgün
MMMehmet Meral
Mehmet Meral
LSLeyla Saglam
Leyla Saglam
Pharmacologic therapies have an important role in the success of interventions for smoking cessation. This study aims to determine the efficacy of several pharmacologic treatments in patients who applied to a smoking cessation clinic.

14 March 2012 in IEEE Transactions on Biomedical Engineering
Verified
Journal Article
Open access
UBUlas Bagci
Ulas Bagci
JYJianhua Yao
Jianhua Yao
AWAlbert Wu
Albert Wu
JCJesus Caban
Jesus Caban
TPTara N. Palmore
Tara N. Palmore
DMDaniel J. Mollura
Daniel J. Mollura
This study presents a novel computer-assisted detection (CAD) system for automatically detecting and precisely quantifying abnormal nodular branching opacities in chest computed tomography (CT), termed tree-in-bud (TIB) opacities by radiology literature. The developed CAD system in this study is based on 1) fast localization of candidate imaging patterns using local scale information of the images, and 2) Möbius invariant feature extraction method based on learned local shape and texture properties of TIB patterns. For fast localization of candidate imaging patterns, we use ball-scale filtering and, based on the observation of the pattern of interest, a suitable scale selection is used to retain only small size patterns. Once candidate abnormality patterns are identified, we extract proposed shape features from regions where at least one candidate pattern occupies. The comparative evaluation of the proposed method with commonly used CAD methods is presented with a dataset of 60 chest CTs (laboratory confirmed 39 viral bronchiolitis human parainfluenza CTs and 21 normal chest CTs). The quantitative results are presented as the area under the receiver operator characteristics curves and a computer score (volume affected by TIB) provided as an output of the CAD system. In addition, a visual grading scheme is applied to the patient data by three well-trained radiologists. Interobserver and observer-computer agreements are obtained by the relevant statistical methods over different lung zones. Experimental results demonstrate that the proposed CAD system can achieve high detection rates with an overall accuracy of 90.96%. Moreover, correlations of observer-observer ( R 2 =0.8848, p <; 0.01) and observer-CAD agreements ( R 2 =0.824, p <; 0.01) validate the feasibility of the use of the proposed CAD system in detecting and quantifying TIB patterns.